Resultats globals: 1 registres trobats en 0.04 segons.
Articles, 1 registres trobats
Articles 1 registres trobats  
1.
12 p, 1.1 MB Fixed-duration ibrutinib plus venetoclax for first-line treatment of CLL : primary analysis of the CAPTIVATE FD cohort / Tam, Constantine S (University of Melbourne) ; Allan, John N (Weill Cornell Medicine) ; Siddiqi, Tanya (City of Hope National Medical Center) ; Kipps, Thomas J. (University of California San Diego) ; Jacobs, Ryan (Levine Cancer Institute) ; Opat, Stephen (Monash University) ; Barr, Paul M. (University of Rochester Medical Center) ; Tedeschi, Alessandra (ASST Grande Ospedale Metropolitano Niguarda) ; Trentin, Livio (University of Padova) ; Bannerji, Rajat (Rutgers Cancer Institute of New Jersey) ; Jackson, Sharon (Middlemore Hospital) ; Kuss, Bryone J. (Flinders University and Medical Center) ; Moreno, Carol (Institut d'Investigació Biomèdica Sant Pau) ; Szafer-Glusman, Edith (Pharmacyclics LLC. an AbbVie Company) ; Russell, Kristin (Pharmacyclics LLC. an AbbVie Company) ; Zhou, Cathy (Pharmacyclics LLC. an AbbVie Company) ; Ninomoto, Joi (Pharmacyclics LLC. an AbbVie Company) ; Dean, James P. (Pharmacyclics LLC. an AbbVie Company) ; Wierda, William G. (DepaUniversity of Texas MD Anderson Cancer Center) ; Ghia, Paolo (IRCCS Ospedale San Raffaele) ; Universitat Autònoma de Barcelona
CAPTIVATE (NCT02910583) is an international phase 2 study in patients aged ≤70 years with previously untreated chronic lymphocytic leukemia (CLL). Results from the cohort investigating fixed-duration (FD) treatment with ibrutinib plus venetoclax are reported. [...]
2022 - 10.1182/blood.2021014488
Blood, Vol. 139 Núm. 22 (february 2022) , p. 3278-3289  

Vegeu també: autors amb noms similars
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.